News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Amstem Corporation (Formerly Known as Stem Cell Therapy International Corp.) To Begin Clinical Study of Cosmeceutical Facial Cream SteMixxTM


9/21/2010 10:59:28 AM

SAN FRANCISCO & SEOUL, Korea--(BUSINESS WIRE)--AmStem Corporation (Pink Sheets: AMST), a leading provider of biotherapeutic and cosmetic stem cell products, stem cell collection and storage expertise and access to nanotechnology vital to stem cell research, announced today that the largest independent, federally regulated Institutional Review Board (IRB) in North America has approved the initial clinical study of the company’s SteMixxTM facial cream. The study is expected to begin this week at the Scottsdale Institute for Cosmetic Dermatology and will last approximately two months.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES